RESPIGAM
RESPIGAM
Discontinued
DIN Number
02232478
Drug Class
Human
Market Date
N/A
Company
HC
MedImmune LLC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02232478
AIG Number0132654001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BA02 IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM.
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification80:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN)Active
Strength: 1000 MG / VIAL
Monograph: RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN)